Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 20 2025

Full Issue

Medical Cannabis Eases Symptoms of Obstructive Sleep Apnea, Study Finds

The data come from Minnesota's Office of Cannabis Management. Also in the news: UTI meds, "menstrual cycle syncing," and a possible height gene.

Sleep apnea is a condition that affects millions of people, often without them even knowing it. It’s more than just loud snoring or restless nights. It can have serious health consequences. And the state Office of Cannabis Management has new data about using cannabis to treat the condition. They conducted the largest survey on record about the condition and cannabis. And their findings show it could really help patients. (Moini and Finn, 5/19)

Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US pharmacies or groceries with a well-stocked health aisle and doesn’t require a prescription. Target Corp. and Walmart Inc. both offer their own generic versions. Given the ease of purchase, it’s a good bet many users assume the drug has been vetted by US regulators and found to be safe and effective. It hasn’t. In fact, the Food and Drug Administration 20 years ago raised questions about whether it truly works, as well as its potential to cause cancer. (Edney, 5/19)

"Menstrual cycle syncing" and "hormonal syncing" are terms used to describe adjusting lifestyle habits to optimize health and wellness at every point of a woman's menstrual cycle. New research by women's health and PMS relief brand Cycl Health has found that there has been a 1,484 percent uptick in global interest in people searching for information about the topic in the last five years, which the brand told Newsweek indicates "a clear intrigue for a more holistic approach to women's self-care." (Willmoth, 5/19)

Men are taller than women, by an average of about five inches. But why? It’s not a genetic inevitability — there are many species in the tree of life where females outclass males. A new study, published on Monday in the Proceedings of the National Academy of Sciences that involved genetic data from a million people, has found a partial explanation. (Kolata, 5/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ